CHEMED CORP (CHE): debt financing — Chemed renews $450M senior secured credit facility for five years

CHEMED CORP

Five-year $450M revolving credit facility includes $100M letters of credit.
Interest rate is SOFR plus tiered spread based on Chemed's leverage ratio.
Facility includes an expansion feature allowing an additional $250M in capacity.
JPMorgan Chase is Administrative Agent; Bank of America, PNC, U.S. Bank also participating.
Credit Agreement dated April 10, 2026; press release issued April 13, 2026.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

CHEMED CORP incurred revolving credit of $450 million with JPMorgan Chase Bank, N.A. at secured overnight financing rate (“SOFR”) plus an additional tiered rate maturing five years.

Instrument: revolving credit
Principal: $450 million
Counterparty: JPMorgan Chase Bank, N.A.
Rate: secured overnight financing rate (“SOFR”) plus an additional tiered rate
Maturity: five years
Event: incurrence

Exact text from the filing

On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CHEMED CORP entered into Sixth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at $450 million (effective 2026-04-10).

Action: entry
Agreement: credit facility
Counterparty: JPMorgan Chase Bank, N.A.
Value: $450 million
Effective: 2026-04-10

Exact text from the filing

On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”).

View on SEC.gov

Browse all debt financings →

CHEMED CORP filing history →

Source: SEC EDGAR

accession 0000019584-26-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.